News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Creyon Bio and Cajal Neuroscience Enter Collaboration to Develop Oligonucleotide-Based Therapies for Neurodegenerative Conditions
Thursday, May 02, 2024Creyon Bio Inc and Cajal Neuroscience have recently announced a collaborative effort to develop innovative treatments for neurodegenerative diseases Creyon specializes
Scenic Biotech Partners with Bristol Myers Squibb for Research Collaboration
Thursday, May 02, 2024Scenic Biotech a leader in the field of modifier therapies for severe genetic disorders has announced a research collaboration with Bristol Myers Squibb aimed at accelerating the development of drug targets owned by Bristol Myers Squibb The collabora...
Medison Pharma and Alnylam Pharmaceuticals Expand Collaboration to Introduce RNAi Therapeutics in Additional LATAM and APAC Territories, Including Australia
Wednesday, May 01, 2024Medison Pharma and Alnylam Pharmaceuticals Inc have announced an expansion of their partnership
Caris Life Sciences and COTA, Inc. Team Up to Broaden Collective Multi-Modal Data Offerings
Wednesday, May 01, 2024Caris Life Sciences a leader in AI TechBio and precision medicine has partnered with COTA Inc an oncology realworld data and analytics firm to enhance their multimodal data offerings
Avenacy Launches Eptifibatide Injection in the U.S. Market
Tuesday, April 30, 2024Avenacy a pharmaceutical company specializing in critical injectable medications has introduced Eptifibatide for Injection in the United States This medication approved by the US Food and Drug Administration serves as a generic equivalent for Integri...
RenAgade Therapeutics expands its dedication to glycobiology through the establishment of GanNA Bio
Monday, April 29, 2024ReNAgade Therapeutics is broadening its scope in RNA medicine through a collaboration with GanNA Bio This partnership aims to explore the potential of glycobiology in therapeutic applications
Vertex Receives European Commission Approval for KALYDECO® to Treat Cystic Fibrosis in Infants as Young as 1 Month Old
Saturday, April 27, 2024Vertex Pharmaceuticals has announced today that the European Commission has granted approval for expanding the use of KALYDECO to include infants as young as monthold with cystic fibrosis
Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, Phase 2 Study Assessing Namilumab for Chronic Pulmonary Sarcoidosis
Friday, April 26, 2024Roivant and Kinevant Sciences have recently announced the successful completion of enrollment in their Phase study assessing namilumabs efficacy in treating chronic pulmonary sarcoidosis
Tetra Pharm Technologies and Glysious Announce Partnership to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System
Thursday, April 25, 2024Tetra Pharm Technologies and Glysious are excited to announce a new collaboration aiming to revolutionize transdermal drug delivery systems The partnership intends to enhance several of Tetra
European Commission Approves FILSPARI® (sparsentan) for IgA Nephropathy Treatment, Joint Announcement by CSL Vifor and Travere Therapeutics
Thursday, April 25, 2024CSL Vifor and Travere Therapeutics Inc jointly announced today that FILSPARI has been granted conditional marketing authorization by the European Commission
